Monoalkylation of DNA by reductively activated FR66979.
The antitumor antibiotic FR66979 has previously been shown to form interstrand cross-links in duplex DNA at the sequence [5'-d(CG)]2, linking the exocyclic amino groups (N2) of deoxyguanosine (dG) residues. During the reaction of reductively activated FR66979 with DNA. products are formed which have electrophoretic mobility in denaturing polyacrylamide gels which is intermediate between that of unmodified and interstrand cross-linked DNA. We show here that these products are monoadducts between FR66979 and DNA and provide strong evidence for the site of alkylation being N2 of dG. Moreover, the sequence selectivity of monoalkylation reactions between FR66979 and DNA containing either 5'-d(CG).5'-d(CI) or [5'-d(CG)]2 was observed to be ca. 5-fold less than for the related antitumor antibiotic mitomycin C (MC). The mechanistic implications of this result are discussed. Furthermore, it was demonstrated that contrary to a previous report, FR66979 requires DNA to be in duplex form for efficient monoadduct formation.
Paz
M M
MM
Department of Chemistry, University of Washington, Seattle 98195-1700, USA.
Sigurdsson
S T
ST
Hopkins
P B
PB
D000478:Alkylation; D001483:Base Sequence; D004247:DNA / Q000737:chemistry*; D018736:DNA Adducts / Q000737:chemistry; D004277:DNA, Single-Stranded / Q000737:chemistry; D007700:Kinetics; D010078:Oxazines / Q000737:chemistry*; D013438:Sulfhydryl Compounds / Q000737:chemistry
D018736:DNA Adducts; D004277:DNA, Single-Stranded; D010078:Oxazines; D013438:Sulfhydryl Compounds; C058745:FR 66979; D004247:DNA